BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) today announced the appointment of Roger J. Garceau M.D., FAAP as senior vice president, research and development and chief medical officer, effective December 11, 2008. Dr. Garceau joins NPS from Sanofi-aventis, where he served in a number of senior leadership positions and brings over 20 years of broad pharmaceutical industry experience to his position. Dr. Garceau replaces Alan G. Harris, M.D., Ph.D. who is leaving NPS for personal reasons but remains as a scientific advisor to the Company.
